This multi-centre, translational phase II trial aims to investigate the impact of the gut microbiome (GM) on treatment o clinical trials

Diet-driven gut microbiome and outcome in patients with early-stage triple-negative breast cancer undergoing neoadjuvant chemotherapy and immunotherapy

This study looks at how the 'good' bacteria in our gut might affect treatment for a type of breast cancer called triple-negative breast cancer. Researchers want to see if changes in diet could help improve how well chemotherapy and immunotherapy work.